Skip to main content
Erschienen in: Clinical Pharmacokinetics 4/2011

01.04.2011 | Short Communication

The Pharmacokinetics of Methanol in the Presence of Ethanol

A Case Study

verfasst von: Dr Carolyn Coulter, Geoffrey K. Isbister, Stephen B. Duffull

Erschienen in: Clinical Pharmacokinetics | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Background and Objective

Methanol is a toxic alcohol that can cause significant morbidity and mortality in overdose, while ethanol is a readily available and effective antidote. Little is known about the pharmacokinetics of methanol in the presence of ethanol and vice versa. This paper explores the influence of methanol and ethanol on the pharmacokinetics of each other along with the effect of continuous venovenous hae-modiafiltration (CVVHD) on alcohol removal.

Methods

Multiple plasma, urine and dialysate samples were collected from a 42-year-old male who ingested 166 g of methanol. Methanol and ethanol concentrations in both plasma and urine were assayed and the concentration-time data were modelled using nonlinear mixed-effects modelling software NONMEM® VI. Simulations were performed using the final model parameters in MATLAB® software where a variety of initial doses and ethanol infusions were assessed.

Results

The final model included a competitive metabolic interaction between methanol and ethanol as well as first-order elimination due to renal, CVVHD and an additional non-renal non-CVVHD mechanism. Simulations from the model show a loading dose of 28.4g/70kg of ethanol results in a target plasma concentration of 1 g/L. Due to the competitive interaction between methanol and ethanol, higher amounts of methanol require lower maintenance doses of ethanol but for longer. CVVHD was shown to increase the dose rate of ethanol required but to decrease the duration of the maintenance phase.

Conclusion

A detailed understanding of the pharmacokinetics of methanol and ethanol in the presence of each other is required to accurately determine the doses of ethanol required to treat different methanol poisonings.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kostic MA, Dart RC. Rethinking the toxic methanol level. J Toxicol Clin Toxicol 2003; 41(6): 793–800PubMedCrossRef Kostic MA, Dart RC. Rethinking the toxic methanol level. J Toxicol Clin Toxicol 2003; 41(6): 793–800PubMedCrossRef
2.
Zurück zum Zitat Jacobsen D, McMartin KE. Antidotes for methanol and ethylene glycol poisoning. J Toxicol Clin Toxicol 1997; 35(2): 127–44PubMedCrossRef Jacobsen D, McMartin KE. Antidotes for methanol and ethylene glycol poisoning. J Toxicol Clin Toxicol 1997; 35(2): 127–44PubMedCrossRef
3.
Zurück zum Zitat Lobert S. Ethanol, isopropanol, methanol, and ethylene glycol poisoning. Crit Care Nurse 2000; 20(6): 41–7PubMed Lobert S. Ethanol, isopropanol, methanol, and ethylene glycol poisoning. Crit Care Nurse 2000; 20(6): 41–7PubMed
4.
Zurück zum Zitat Hovda KE, Hunderi OH, Tafjord A-B, et al. Methanol outbreak in Norway 2002–2004: epidemiology, clinical features and prognostic signs. J Intern Med 2005; 258: 181–90PubMedCrossRef Hovda KE, Hunderi OH, Tafjord A-B, et al. Methanol outbreak in Norway 2002–2004: epidemiology, clinical features and prognostic signs. J Intern Med 2005; 258: 181–90PubMedCrossRef
5.
Zurück zum Zitat Roe O. Species differences in methanol poisoning. Cri Rev Toxicol 1982; 10: 275–86CrossRef Roe O. Species differences in methanol poisoning. Cri Rev Toxicol 1982; 10: 275–86CrossRef
6.
Zurück zum Zitat Ekins BR, Rollins DE, Duffy DP, et al. Standardized treatment of severe methanol poisoning with ethanol and hemodialysis. West J Med 1985; 142(3): 337–40PubMed Ekins BR, Rollins DE, Duffy DP, et al. Standardized treatment of severe methanol poisoning with ethanol and hemodialysis. West J Med 1985; 142(3): 337–40PubMed
7.
Zurück zum Zitat Lushine KA, Harris CR, Holger JS. Methanol ingestion: prevention of toxic sequelae after massive ingestion. J Emerg Med 2003; 24(4): 433–6PubMedCrossRef Lushine KA, Harris CR, Holger JS. Methanol ingestion: prevention of toxic sequelae after massive ingestion. J Emerg Med 2003; 24(4): 433–6PubMedCrossRef
8.
Zurück zum Zitat Meyer RJ, Beard MEJ, Ardagh MW, et al. Methanol poisoning. N Z Med J 2000; 113: 11–3PubMed Meyer RJ, Beard MEJ, Ardagh MW, et al. Methanol poisoning. N Z Med J 2000; 113: 11–3PubMed
9.
Zurück zum Zitat Hantson P, Haufroid V, Wallemacq P. Formate kinetics in methanol poisoning. Hum Exp Toxicol 2005; 24: 55–9PubMedCrossRef Hantson P, Haufroid V, Wallemacq P. Formate kinetics in methanol poisoning. Hum Exp Toxicol 2005; 24: 55–9PubMedCrossRef
10.
Zurück zum Zitat McMartin KE, Ambre JJ, Tephly TR. Methanol poisoning in human subjects. Am J Med 1980; 68: 414–8PubMedCrossRef McMartin KE, Ambre JJ, Tephly TR. Methanol poisoning in human subjects. Am J Med 1980; 68: 414–8PubMedCrossRef
11.
Zurück zum Zitat Jacobsen D, McMartin K. Methanol and formaldehyde poisoning. In: Brent J, Wallace K, Burkhart K, et al., editors. Critical care toxiology. Philadelphia (PA): Elsevier Mosby, 2005 Jacobsen D, McMartin K. Methanol and formaldehyde poisoning. In: Brent J, Wallace K, Burkhart K, et al., editors. Critical care toxiology. Philadelphia (PA): Elsevier Mosby, 2005
12.
Zurück zum Zitat Brent J, McMartin K, Phillips S, et al. Fomepizole for the treatment of methanol poisoning. N Engl J Med 2001; 344(6): 424–9PubMedCrossRef Brent J, McMartin K, Phillips S, et al. Fomepizole for the treatment of methanol poisoning. N Engl J Med 2001; 344(6): 424–9PubMedCrossRef
13.
14.
Zurück zum Zitat Druteika DP, Zed PJ, Ensom MHH. Role of fomepizole in the management of ethylene glycol toxicity: treatment. Pharmacotherapy 2002; 22(3): 365–72PubMedCrossRef Druteika DP, Zed PJ, Ensom MHH. Role of fomepizole in the management of ethylene glycol toxicity: treatment. Pharmacotherapy 2002; 22(3): 365–72PubMedCrossRef
15.
Zurück zum Zitat Barceloux DG, Bond GR, Krenzelok EP, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. Clin Toxicol 2002; 40(4): 415–46CrossRef Barceloux DG, Bond GR, Krenzelok EP, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. Clin Toxicol 2002; 40(4): 415–46CrossRef
16.
Zurück zum Zitat Brent J. Fomepizole for ethylene glycol and methanol poisoning. N Engl J Med 2009; 360: 2216–23PubMedCrossRef Brent J. Fomepizole for ethylene glycol and methanol poisoning. N Engl J Med 2009; 360: 2216–23PubMedCrossRef
17.
Zurück zum Zitat Norberg A, Jones WA, Hahn R, et al. Role of variability in explaining ethanol pharmacokinetics. Clin Pharmacokinet 2003; 42(1): 1–3PubMedCrossRef Norberg A, Jones WA, Hahn R, et al. Role of variability in explaining ethanol pharmacokinetics. Clin Pharmacokinet 2003; 42(1): 1–3PubMedCrossRef
18.
Zurück zum Zitat Kan G, Jenkins I, Rangan G, et al. Continuous haemodiafiltration compared with intermittent haemodialysis in the treatment of methanol poisoning. Nephrol Dial Transplant 2003; 18: 2665–7PubMedCrossRef Kan G, Jenkins I, Rangan G, et al. Continuous haemodiafiltration compared with intermittent haemodialysis in the treatment of methanol poisoning. Nephrol Dial Transplant 2003; 18: 2665–7PubMedCrossRef
19.
Zurück zum Zitat Sivilotti MLA, Burns MJ, Aaron CK. Reversal of severe methanol-induced visual impairment: no evidence of retinal toxicity due to fomepizole. Clin Tox 2001; 39(6): 627–31CrossRef Sivilotti MLA, Burns MJ, Aaron CK. Reversal of severe methanol-induced visual impairment: no evidence of retinal toxicity due to fomepizole. Clin Tox 2001; 39(6): 627–31CrossRef
20.
Zurück zum Zitat Megarbane B, Borron SW, Baud F. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med 2005; 31:189–95PubMedCrossRef Megarbane B, Borron SW, Baud F. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med 2005; 31:189–95PubMedCrossRef
21.
Zurück zum Zitat Bestic M, Blackford M, Reed M. Fomepizole: a critical assessment of current dosing regimens. J Clin Pharmacol 2009; 49: 130–7PubMedCrossRef Bestic M, Blackford M, Reed M. Fomepizole: a critical assessment of current dosing regimens. J Clin Pharmacol 2009; 49: 130–7PubMedCrossRef
22.
23.
Zurück zum Zitat Corley RA, Bartels MJ, Carney EW, et al. Development of a physiologically based pharmacokinetic model for ethylene glycol and its metabolite, glycolic acid, in rats and humans. Toxicol Sci 2005; 85(1): 476–90PubMedCrossRef Corley RA, Bartels MJ, Carney EW, et al. Development of a physiologically based pharmacokinetic model for ethylene glycol and its metabolite, glycolic acid, in rats and humans. Toxicol Sci 2005; 85(1): 476–90PubMedCrossRef
24.
Zurück zum Zitat Haffner H-T, Wehner H-D, Scheytt K-D, et al. The elimination kinetics of methanol and the influence of ethanol. Int Legal Med 1992; 105(2): 111–4CrossRef Haffner H-T, Wehner H-D, Scheytt K-D, et al. The elimination kinetics of methanol and the influence of ethanol. Int Legal Med 1992; 105(2): 111–4CrossRef
25.
Zurück zum Zitat Graw M, Haffner H-T, Althaus L, et al. Invasion and distribution of methanol. Arch Toxicol 2000; 74(6): 313–21PubMedCrossRef Graw M, Haffner H-T, Althaus L, et al. Invasion and distribution of methanol. Arch Toxicol 2000; 74(6): 313–21PubMedCrossRef
26.
Zurück zum Zitat Dawidek-Pietryka K, Szczepaniak S, Dudka J, et al. In vitro studies of human alcohol dehydrogenase inhibition in the process of methanol and ethylene glycol oxidation. Arch Toxicol 1998; 72: 604–7PubMedCrossRef Dawidek-Pietryka K, Szczepaniak S, Dudka J, et al. In vitro studies of human alcohol dehydrogenase inhibition in the process of methanol and ethylene glycol oxidation. Arch Toxicol 1998; 72: 604–7PubMedCrossRef
27.
Zurück zum Zitat Wagner FW, Burger AR, Vallee BL. Kinetic properties of human liver alcohol dehydrogenase: oxidation of alcohols by class I isoenzymes. Biochemistry 1983; 22(8): 1857–63PubMedCrossRef Wagner FW, Burger AR, Vallee BL. Kinetic properties of human liver alcohol dehydrogenase: oxidation of alcohols by class I isoenzymes. Biochemistry 1983; 22(8): 1857–63PubMedCrossRef
Metadaten
Titel
The Pharmacokinetics of Methanol in the Presence of Ethanol
A Case Study
verfasst von
Dr Carolyn Coulter
Geoffrey K. Isbister
Stephen B. Duffull
Publikationsdatum
01.04.2011
Verlag
Springer International Publishing
Erschienen in
Clinical Pharmacokinetics / Ausgabe 4/2011
Print ISSN: 0312-5963
Elektronische ISSN: 1179-1926
DOI
https://doi.org/10.2165/11584250-000000000-00000

Weitere Artikel der Ausgabe 4/2011

Clinical Pharmacokinetics 4/2011 Zur Ausgabe